These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. Special studies of diclofenac and safety: gastrointestinal, renal, hepatic, and other consequences of therapy. Roth SH Semin Arthritis Rheum; 1985 Nov; 15(2 Suppl 1):99-104. PubMed ID: 4081797 [No Abstract] [Full Text] [Related]
69. Withdrawal of alclofenac (Prinalgin). Mann RD Br Med J; 1979 Jul; 2(6182):133. PubMed ID: 37982 [No Abstract] [Full Text] [Related]
70. Withdrawal of alclofenac (Prinalgin). Mann RD Lancet; 1979 Jul; 2(8132):52. PubMed ID: 87941 [No Abstract] [Full Text] [Related]
76. Accidental interaction between PDZ domains and diclofenac revealed by NMR-assisted virtual screening. Tenno T; Goda N; Umetsu Y; Ota M; Kinoshita K; Hiroaki H Molecules; 2013 Aug; 18(8):9567-81. PubMed ID: 23966078 [TBL] [Abstract][Full Text] [Related]
77. The effect of diclofenac Na (Voltarol) on the haematopoietic cells of bone marrow in sheep. Naeini AT; Zakerinia M; Hosseini E Vet Res Commun; 1998 Sep; 22(6):401-3. PubMed ID: 9810636 [No Abstract] [Full Text] [Related]
78. Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Brogden RN; Heel RC; Pakes GE; Speight TM; Avery GS Drugs; 1980 Jul; 20(1):24-48. PubMed ID: 6772422 [TBL] [Abstract][Full Text] [Related]